RKI-1313

• Catalog number
  B1092-25
• Price
  Please ask
• Size
  25 mg

• Alternative_name
  1-(3-Methoxybenzyl)-3-[4-(pyridin-4-yl)thiazol-2-yl]urea
• Description
  RKI-1313 weak inhibitor for ROCK2-dependent signaling and has less effect on phosphorylation levels of ROCK substrates. RKI-1313 serves as a negative control for RKI-1447 (Cat. No. 2472) which is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.
• CAS Number
  1342276-76-9
• Structure Available
  Yes
• Salt Form
  No
• Molecular Formula
  C₁₇H₁₆N₄O₂S
• Molecular Weight
  340.4
• Cell Permeable
  Yes
• Purity
  ≥98% by HPLC
• Solubilities
  DMSO
• Handling
  Protect from air and light
• Tag Line
  A useful negative control for RKI-1447 (Cat.No. 2472)
• Storage Condition
  -20°C
• Shipping Condition
  gel pack
• Shelf Life
  36 months
• PubChem CID
  53492330
• PubChem CID Link
• SMILES
  COC1=CC=CC(=C1)CNC(=O)NC2=NC(=CS2)C3=CC=NC=C3
• InChi
  InChI=1S/C17H16N4O2S/c1-23-14-4-2-3-12(9-14)10-19-16(22)21-17-20-15(11-24-17)13-5-7-18-8-6-13/h2-9,11H,10H2,1H3,(H2,19,20,21,22)
• InChi Key
  BDCUKYUIVYKXCQ-UHFFFAOYSA-N
• Data Sheet Link
• MSDS Available
  Yes

• Gene target
  RKI-1313  
• Short name
  RKI-1313
• Alternative name
  RKI-1313

Product images

Similar products